| '''FDA Asbestos Finding''' || 15% of cosmetic talc products (2018–2022)
...usative agent — not merely a contaminant carrier.<ref name="moline2023" /> FDA testing of cosmetic talc products from 2018 through 2022 detected asbestos
...
24 KB (3,304 words) - 14:36, 3 April 2026
...t established immunotherapy as the new standard of care in 2020.<ref name="fda-nivo-ipi" /> Today, researchers are exploring CAR-T cell therapy, gene ther
...18 months or longer with modern multimodal treatment approaches. The 2020 FDA approval of nivolumab plus ipilimumab marked the first new systemic therapy
...
38 KB (4,755 words) - 03:42, 9 March 2026
...isease, and cellular therapies demonstrating unprecedented durability. The FDA approved '''pembrolizumab plus chemotherapy''' in September 2024 as a new f
...2% response with pembrolizumab-chemo vs 29% with chemo alone''' — the 2024 FDA-approved combination nearly doubles confirmed response rates in first-line
...
39 KB (4,791 words) - 23:07, 10 March 2026
...ucts from 1930s hair dryers to modern talc cosmetics. Covers CPSC recalls, FDA testing, J&J litigation, EPA bans, and testing methods.
...ion, asbestos hair dryers, Johnson and Johnson talc, asbestos baby powder, FDA talc testing, CPSC asbestos recall, asbestos popcorn ceiling, asbestos floo
...
67 KB (8,729 words) - 01:12, 6 April 2026
== Asbestos Regulations & Ban History ==
* [[US Asbestos Ban History and Regulations]] — Hub: full regulatory timeline from 1930s cover-ups to the 2024 chrysoti
...
23 KB (2,626 words) - 01:08, 6 April 2026
| '''Mesothelin Biomarker Accuracy''' || 61% sensitivity, 87% specificity; FDA-approved diagnostic marker<ref name="biomarkerdata" />
...' || Immunotherapy median OS 18.1 months vs. 14.1 months for chemotherapy; FDA approved October 2020<ref name="checkmate743" />
...
43 KB (5,354 words) - 03:51, 9 March 2026
...ely justified why a comprehensive ban was less burdensome than alternative regulations.<ref name="1989_ban_reversal" /> The Lautenberg Act removed this obstacle.
Legal analysis by Danziger & De Llano indicates that in November 2025, the FDA withdrew its proposed rule banning talc powder contaminated with asbestos,
...
25 KB (3,336 words) - 09:56, 6 April 2026
* '''Biomarker sensitivity vs. imaging''' — the only FDA-cleared mesothelioma blood test (MESOMARK) detects just 32% of cases at 95%
...0px; border-bottom:1px solid #555;" | 32% sensitivity at 95% specificity — FDA-cleared for monitoring, not population screening
...
50 KB (6,457 words) - 09:18, 6 April 2026
| style="padding:10px; border-bottom:1px solid #dee2e6;" | '''FDA-Approved Systemic Regimens'''
...ssay (measuring soluble mesothelin-related peptides/SMRP) remains the only FDA-approved blood biomarker, cleared in 2007 for monitoring treatment response
...
62 KB (7,831 words) - 01:11, 6 April 2026
...tps://www.epa.gov/asbestos/asbestos-laws-and-regulations Asbestos Laws and Regulations], U.S. Environmental Protection Agency</ref> (2) '''Consumer products''' av
* Regulatory oversight: Minimal FDA/EPA/CPSC oversight of asbestos products before 1973
...
67 KB (8,579 words) - 10:18, 6 April 2026
...ival to 18.8 months, though this remains off-label. September 2024 brought FDA approval of pembrolizumab combined with chemotherapy, offering improved 3-y
...ost important chemotherapy agent for mesothelioma treatment since its 2004 FDA approval for first-line use in combination with platinum-based agents.
...
216 KB (26,444 words) - 23:30, 23 January 2026
